Retatrutide is a new medication in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, exhibits promising results in research studies. By activating these receptors, https://saulxuyg240447.activablog.com/35301613/retatrutide-a-promising-new-treatment-for-obesity